Form 4: Director Angela S. Lalor Increases Stake in Enovis Corp

Director Angela S. Lalor acquired 9,346 shares of Enovis Corp common stock as part of a compensation-related grant.

Summary

• Director Angela S. Lalor acquired 9,346 shares of Enovis Corp (ENOV) common stock.
• The transaction occurred on May 19, 2026.
• The shares were acquired at a price of $0.00, indicating an equity grant rather than a market purchase.
• Following this transaction, the director's total beneficial ownership increased to 31,486 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Increased alignment between the director and shareholders through higher equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align board member interests with long-term shareholder value in the medical technology sector.

Comparison to Industry Standards

• The acquisition of equity by directors is a standard practice across the S&P 400 and medical device industry to ensure board commitment.

Stakeholder Impact

• Positive signal for shareholders as it reflects director commitment to the company.

Next Steps

• None.

Key Dates

Keywords

Enovis, ENOV, Insider Trading, Form 4, Director Ownership